An epigenetic marker panel for screening and prognostic prediction of ovarian cancer

Her Young Su; Hung Cheng Lai; Ya Wen Lin; Yu Ching Chou; Chin Yu Liu; Mu Hsien Yu

doi:10.1002/ijc.23957

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer

Her Young Su, Hung Cheng Lai, Ya Wen Lin, Yu Ching Chou, Chin Yu Liu, Mu Hsien Yu

Research output: Contribution to journal › Article › peer-review

115 Citations (Scopus)

Abstract

Aberrant CpG island hypermethylation is a common finding of cancers, which might be detectable in the tissue or serum of affected patients. We analyzed DNA methylation by methylation-specific polymerase chain reaction of 7 genes, which included secreted frizzled receptor proteins 1, 2, 4, 5 (SFRPI, 2, 4, 5), SRY-box 1 (SOX1), paired box gene 1 (PAX1) and LIM homeobox transcription factor 1, alpha (LMX1A) in primary tumor samples from 126 patients with ovarian cancer, 75 with a benign tumor and 14 with borderline malignancy of an ovarian tumor, and in the serum from 26 patients with ovarian cancer and 20 with a benign tumor. Six of 7 genes had higher methylation rates in patients with ovarian cancer than in borderline malignancy or benign tumor (p

Original language	English
Pages (from-to)	387-393
Number of pages	7
Journal	International Journal of Cancer
Volume	124
Issue number	2
DOIs	https://doi.org/10.1002/ijc.23957
Publication status	Published - Jan 15 2009
Externally published	Yes

Keywords

Cpg islands
Epigenetics
Methylation-specific pcr
Ovarian cancer

ASJC Scopus subject areas

Cancer Research
Oncology
Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.23957

Cite this

@article{fa5a72842f8047dcace4d039ccb29f31,

title = "An epigenetic marker panel for screening and prognostic prediction of ovarian cancer",

abstract = "Aberrant CpG island hypermethylation is a common finding of cancers, which might be detectable in the tissue or serum of affected patients. We analyzed DNA methylation by methylation-specific polymerase chain reaction of 7 genes, which included secreted frizzled receptor proteins 1, 2, 4, 5 (SFRPI, 2, 4, 5), SRY-box 1 (SOX1), paired box gene 1 (PAX1) and LIM homeobox transcription factor 1, alpha (LMX1A) in primary tumor samples from 126 patients with ovarian cancer, 75 with a benign tumor and 14 with borderline malignancy of an ovarian tumor, and in the serum from 26 patients with ovarian cancer and 20 with a benign tumor. Six of 7 genes had higher methylation rates in patients with ovarian cancer than in borderline malignancy or benign tumor (p ",

keywords = "Cpg islands, Epigenetics, Methylation-specific pcr, Ovarian cancer",

author = "Su, {Her Young} and Lai, {Hung Cheng} and Lin, {Ya Wen} and Chou, {Yu Ching} and Liu, {Chin Yu} and Yu, {Mu Hsien}",

year = "2009",

month = jan,

day = "15",

doi = "10.1002/ijc.23957",

language = "English",

volume = "124",

pages = "387--393",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - An epigenetic marker panel for screening and prognostic prediction of ovarian cancer

AU - Su, Her Young

AU - Lai, Hung Cheng

AU - Lin, Ya Wen

AU - Chou, Yu Ching

AU - Liu, Chin Yu

AU - Yu, Mu Hsien

PY - 2009/1/15

Y1 - 2009/1/15

N2 - Aberrant CpG island hypermethylation is a common finding of cancers, which might be detectable in the tissue or serum of affected patients. We analyzed DNA methylation by methylation-specific polymerase chain reaction of 7 genes, which included secreted frizzled receptor proteins 1, 2, 4, 5 (SFRPI, 2, 4, 5), SRY-box 1 (SOX1), paired box gene 1 (PAX1) and LIM homeobox transcription factor 1, alpha (LMX1A) in primary tumor samples from 126 patients with ovarian cancer, 75 with a benign tumor and 14 with borderline malignancy of an ovarian tumor, and in the serum from 26 patients with ovarian cancer and 20 with a benign tumor. Six of 7 genes had higher methylation rates in patients with ovarian cancer than in borderline malignancy or benign tumor (p

AB - Aberrant CpG island hypermethylation is a common finding of cancers, which might be detectable in the tissue or serum of affected patients. We analyzed DNA methylation by methylation-specific polymerase chain reaction of 7 genes, which included secreted frizzled receptor proteins 1, 2, 4, 5 (SFRPI, 2, 4, 5), SRY-box 1 (SOX1), paired box gene 1 (PAX1) and LIM homeobox transcription factor 1, alpha (LMX1A) in primary tumor samples from 126 patients with ovarian cancer, 75 with a benign tumor and 14 with borderline malignancy of an ovarian tumor, and in the serum from 26 patients with ovarian cancer and 20 with a benign tumor. Six of 7 genes had higher methylation rates in patients with ovarian cancer than in borderline malignancy or benign tumor (p

KW - Cpg islands

KW - Epigenetics

KW - Methylation-specific pcr

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=58249087346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249087346&partnerID=8YFLogxK

U2 - 10.1002/ijc.23957

DO - 10.1002/ijc.23957

M3 - Article

C2 - 18942711

AN - SCOPUS:58249087346

VL - 124

SP - 387

EP - 393

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this